The effect of metformin on biomarkers associated with breast cancer outcomes: a systematic review, meta-analysis, and dose–response of randomized clinical trials

J. Rahmani, N. Manzari, J. Thompson, S. K. Gudi, M. Chhabra, G. Naik, S. M. Mousavi, H. K. Varkaneh, C. Clark, Y. Zhang*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    23 Citations (SciVal)
    Original languageEnglish
    Pages (from-to)37-49
    Number of pages13
    JournalClinical and Translational Oncology
    Volume22
    Issue number1
    DOIs
    Publication statusPublished (VoR) - 1 Jan 2020

    Keywords

    • BMI
    • Breast cancer
    • Glucose
    • Insulin
    • Ki-67
    • Metformin

    Fingerprint

    Dive into the research topics of 'The effect of metformin on biomarkers associated with breast cancer outcomes: a systematic review, meta-analysis, and dose–response of randomized clinical trials'. Together they form a unique fingerprint.

    Cite this